Hoth Therapeutics, Inc. ·

HOTH 8-K 2026-01-16

Hoth Therapeutics, Inc. (HOTH) 8-K dated 2026-01-16 — accession 0001213900-26-004899. This URL is the filing, not the HOTH hub.

Hoth Therapeutics, Inc. (HOTH) is a biotechnology company listed on US.

Hoth Therapeutics, Inc. filed a 8-K on 2026-01-16. Accession 0001213900-26-004899.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.

Not investment advice. The HOTH SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR